VA Primary Care and Mental Health Providers' Comfort with Genetic Testing: Survey Results from the PRIME Care Study.
作者信息
Hull Leland E, Lynch Kevin G, Oslin David W
机构信息
Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, Boston, MA, USA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
出版信息
J Gen Intern Med. 2019 Jun;34(6):799-801. doi: 10.1007/s11606-018-4776-0.
Abstract
摘要
相似文献
1
VA Primary Care and Mental Health Providers' Comfort with Genetic Testing: Survey Results from the PRIME Care Study.美国退伍军人事务部初级保健和心理健康服务提供者对基因检测的接受程度：PRIME 护理研究的调查结果。
J Gen Intern Med. 2019 Jun;34(6):799-801. doi: 10.1007/s11606-018-4776-0.
2
Influence of schizophrenia diagnosis on providers' practice decisions.精神分裂症诊断对医疗服务提供者实践决策的影响。
J Clin Psychiatry. 2015 Aug;76(8):1068-74; quiz 1074. doi: 10.4088/JCP.14m09465.
3
Healthcare providers' attitudes toward persons with schizophrenia.医疗服务提供者对精神分裂症患者的态度。
Psychiatr Rehabil J. 2014 Dec;37(4):297-303. doi: 10.1037/prj0000095. Epub 2014 Oct 13.
4
A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program.阿 Survey 医生的 Attitudes，Knowledge，Comfort，and 恐惧的后果与阿 Opioid 过量教育和纳洛酮分发程序。
J Public Health Manag Pract. 2018 Jul/Aug;24(4):310-317. doi: 10.1097/PHH.0000000000000668.
5
Veterans Affairs Primary Care Provider Perceptions of Insomnia Treatment.退伍军人事务初级保健提供者对失眠治疗的看法。
J Clin Sleep Med. 2017 Aug 15;13(8):991-999. doi: 10.5664/jcsm.6702.
6
Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists.COVID-19 大流行期间风湿性疾病的管理：风湿病专家对退伍军人事务部的全国性调查。
Arthritis Care Res (Hoboken). 2021 Jul;73(7):998-1003. doi: 10.1002/acr.24487.
7
8
Addressing Patients' Veteran Status: Primary Care Providers' Knowledge, Comfort, and Educational Needs.关注患者的退伍军人身份：初级保健提供者的知识、舒适度及教育需求。
Fam Med. 2018 Jun;50(6):455-459. doi: 10.22454/FamMed.2018.795504.
9
A Mixed-Methods Study of Veterans Affairs Providers' Experiences Communicating With Patients About the Affordable Care Act.一项关于退伍军人事务部提供者与患者就《平价医疗法案》进行沟通的经验的混合方法研究。
Mil Med. 2017 May;182(5):e1715-e1723. doi: 10.7205/MILMED-D-16-00354.
10
Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.初级保健提供者对使用基因检测来指导酒精使用障碍治疗的兴趣。
J Subst Abuse Treat. 2016 Nov;70:14-20. doi: 10.1016/j.jsat.2016.07.009. Epub 2016 Jul 30.
引用本文的文献
1
The Perceived Value of Pharmacogenetic Testing in Depression Treatment: Mixed-Methods Results From the PRIME Care Study.药物基因检测在抑郁症治疗中的感知价值：PRIME 护理研究的混合方法结果
Psychiatr Serv. 2025 Jun 1;76(6):589-597. doi: 10.1176/appi.ps.20240080. Epub 2025 Apr 16.
2
The Diagnostic Landscape of Adult Neurogenetic Disorders.成人神经遗传性疾病的诊断概况
Biology (Basel). 2023 Nov 22;12(12):1459. doi: 10.3390/biology12121459.
3
Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews.提供者使用药物遗传学检测来指导抗抑郁药物处方：定性访谈的结果。
Psychiatr Serv. 2023 Dec 1;74(12):1270-1276. doi: 10.1176/appi.ps.20220537. Epub 2023 Aug 2.
4
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.药物基因相互作用的药物基因组检测对重度抑郁症患者药物选择和症状缓解的影响：PRIME Care 随机临床试验。
JAMA. 2022 Jul 12;328(2):151-161. doi: 10.1001/jama.2022.9805.
5
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.用于评估实施研究综合框架构建要素的最佳-最差尺度法：在抗抑郁治疗药物遗传学检测实施中的应用
Implement Sci Commun. 2022 May 14;3(1):52. doi: 10.1186/s43058-022-00300-7.
6
Analysis of genetic and clinical factors associated with buprenorphine response.分析与丁丙诺啡反应相关的遗传和临床因素。
Drug Alcohol Depend. 2021 Oct 1;227:109013. doi: 10.1016/j.drugalcdep.2021.109013. Epub 2021 Aug 28.
7
Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners.精神病学中的药物遗传学：智利从业者样本中的感知价值与观点
Front Pharmacol. 2021 Apr 15;12:657985. doi: 10.3389/fphar.2021.657985. eCollection 2021.
8
Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.初级保健和精神健康提供者对实施用于抑郁症处方的药物遗传学检测的看法。
BMC Psychiatry. 2020 Oct 28;20(1):518. doi: 10.1186/s12888-020-02919-z.
9
Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System.确定电子健康记录系统中药物基因组学检测订单结构的终端用户偏好。
J Mol Diagn. 2020 Oct;22(10):1264-1271. doi: 10.1016/j.jmoldx.2020.06.015.
10
Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to Application.研究生命周期以提高研究的实质性实际影响：加速创新到应用。
Med Care. 2019 Oct;57 Suppl 10 Suppl 3(10 Suppl 3):S206-S212. doi: 10.1097/MLR.0000000000001146.
本文引用的文献
1
Pharmacogenomics in the clinic.临床中的药物基因组学。
Nature. 2015 Oct 15;526(7573):343-50. doi: 10.1038/nature15817.
2
Comparison of delivery strategies for pharmacogenetic testing services.比较药物遗传学检测服务的不同传递策略。
Pharmacogenet Genomics. 2014 Mar;24(3):139-45. doi: 10.1097/FPC.0000000000000028.
3
Primary care physicians' knowledge of and experience with pharmacogenetic testing.初级保健医生对药物基因组学检测的认识和经验。
Clin Genet. 2012 Oct;82(4):388-94. doi: 10.1111/j.1399-0004.2012.01908.x. Epub 2012 Jul 3.
4
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.美国医生采用药物基因组学检测的情况：全国性调查结果。
Clin Pharmacol Ther. 2012 Mar;91(3):450-8. doi: 10.1038/clpt.2011.306. Epub 2012 Jan 25.
Zotero 插件